JP2002537329A5 - - Google Patents

Download PDF

Info

Publication number
JP2002537329A5
JP2002537329A5 JP2000600636A JP2000600636A JP2002537329A5 JP 2002537329 A5 JP2002537329 A5 JP 2002537329A5 JP 2000600636 A JP2000600636 A JP 2000600636A JP 2000600636 A JP2000600636 A JP 2000600636A JP 2002537329 A5 JP2002537329 A5 JP 2002537329A5
Authority
JP
Japan
Prior art keywords
alkyl
pharmaceutical composition
hydrogen
alkylamino
amino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000600636A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002537329A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2000/005282 external-priority patent/WO2000050024A2/en
Publication of JP2002537329A publication Critical patent/JP2002537329A/ja
Publication of JP2002537329A5 publication Critical patent/JP2002537329A5/ja
Pending legal-status Critical Current

Links

JP2000600636A 1999-02-26 2000-02-25 特定のウリジン、アデニン及びシチジン二リン酸並びにそれらの類似体による粘膜水和の促進方法 Pending JP2002537329A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12175499P 1999-02-26 1999-02-26
US60/121,754 1999-02-26
PCT/US2000/005282 WO2000050024A2 (en) 1999-02-26 2000-02-25 Method of promoting mucosal hydration with certain uridine, adenine and cytidine diphosphates and analogs thereof

Publications (2)

Publication Number Publication Date
JP2002537329A JP2002537329A (ja) 2002-11-05
JP2002537329A5 true JP2002537329A5 (cg-RX-API-DMAC7.html) 2007-04-19

Family

ID=22398588

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000600636A Pending JP2002537329A (ja) 1999-02-26 2000-02-25 特定のウリジン、アデニン及びシチジン二リン酸並びにそれらの類似体による粘膜水和の促進方法

Country Status (12)

Country Link
US (2) US6331529B1 (cg-RX-API-DMAC7.html)
EP (1) EP1161246B1 (cg-RX-API-DMAC7.html)
JP (1) JP2002537329A (cg-RX-API-DMAC7.html)
KR (1) KR20010114214A (cg-RX-API-DMAC7.html)
AR (1) AR023088A1 (cg-RX-API-DMAC7.html)
AT (1) ATE281837T1 (cg-RX-API-DMAC7.html)
AU (1) AU3612600A (cg-RX-API-DMAC7.html)
BR (1) BR0008498A (cg-RX-API-DMAC7.html)
CA (1) CA2359891A1 (cg-RX-API-DMAC7.html)
DE (1) DE60015734D1 (cg-RX-API-DMAC7.html)
MX (1) MXPA01008547A (cg-RX-API-DMAC7.html)
WO (1) WO2000050024A2 (cg-RX-API-DMAC7.html)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6319908B1 (en) 1996-07-03 2001-11-20 Inspire Pharmaceuticals, Inc. Method for large-scale production of di(uridine 5′-tetraphosphate) and salts thereof
US5763447C1 (en) 1996-07-23 2002-05-07 Inspire Pharmaceuticals Method of preventing or treating pneumonia in immobilized patients with uridine triphosphates and related compounds
US6872710B2 (en) 1997-07-25 2005-03-29 Inspire Pharmaceuticals, Inc. Di(uridine 5′)-tetraphosphate and salts thereof
CA2295515C (en) 1997-07-25 2006-03-14 Inspire Pharmaceuticals, Inc. Method for large-scale production of di(uridine 5'-tetraphosphate) and salts thereof
TW593331B (en) 1997-07-25 2004-06-21 Inspire Pharmaceuticals Inc Method for large-scale production of di(uridine 5')-tetraphosphate and salts thereof
US6432454B1 (en) * 1997-12-12 2002-08-13 C. V. Technologies, Inc. Processes of making north american ginseng fractions, products containing them, and use as immunomodulators
US6624150B2 (en) 1999-02-26 2003-09-23 Inspire Pharmaceuticals, Inc. Method of treating gastrointestinal tract disease with purinergic receptor agonists
KR20010114214A (ko) 1999-02-26 2001-12-31 인스파이어 파마슈티컬스 인코퍼레이티드 우리딘, 아데닌 및 시티딘 디포스페이트 및 그의 유사체에의한 점막수화 촉진방법
US6576224B1 (en) * 1999-07-06 2003-06-10 Sinuspharma, Inc. Aerosolized anti-infectives, anti-inflammatories, and decongestants for the treatment of sinusitis
US20020061281A1 (en) * 1999-07-06 2002-05-23 Osbakken Robert S. Aerosolized anti-infectives, anti-inflammatories, and decongestants for the treatment of sinusitis
JP2003524636A (ja) * 1999-12-22 2003-08-19 インスパイアー ファーマシューティカルズ,インコーポレイティド プリン性受容体アゴニストによる胃腸管の処置方法
US6864243B1 (en) * 2000-05-12 2005-03-08 Inspire Pharmaceuticals, Inc. Method for treating retinal degeneration with purinergic receptor agonists
AU2001260643B9 (en) 2000-05-30 2006-10-19 Merck Sharp & Dohme Corp. Ectocornea extension promoters
US6867199B2 (en) 2000-08-21 2005-03-15 Inspire Pharmaceuticals, Inc. Dinucleoside polyphosphate compositions and their therapeutic use
US6555675B2 (en) 2000-08-21 2003-04-29 Inspire Pharmaceuticals, Inc. Dinucleoside polyphosphate compositions and their therapuetic use as purinergic receptor agonists
US7452870B2 (en) 2000-08-21 2008-11-18 Inspire Pharmaceuticals, Inc. Drug-eluting stents coated with P2Y12 receptor antagonist compound
US7132408B2 (en) 2000-08-21 2006-11-07 Inspire Pharmaceuticals, Inc. Composition and method for inhibiting platelet aggregation
US7018985B1 (en) 2000-08-21 2006-03-28 Inspire Pharmaceuticals, Inc. Composition and method for inhibiting platelet aggregation
WO2003000056A1 (en) 2001-06-25 2003-01-03 Inspire Pharmaceuticals, Inc. Joint lubrication with p2y purinergic receptor agonists
MXPA04004215A (es) 2001-11-06 2004-07-08 Inspire Pharmaceuticals Inc Metodo para el tratamiento o la prevencion de enfermedades inflamatorias.
US6858615B2 (en) 2002-02-19 2005-02-22 Parion Sciences, Inc. Phenyl guanidine sodium channel blockers
US7179481B2 (en) * 2002-09-19 2007-02-20 Kimberly-Clark Worldwide, Inc. Vaginal health products
MXPA05004121A (es) * 2002-10-18 2006-02-17 Molichem Medicines Inc Metodos para tratar la enfermedad de ojo reseco con lantibioticos.
US7056889B2 (en) 2002-12-16 2006-06-06 Kimberly-Clark, Worldwide, Inc. Compounds that bind P2Y2 or P2Y1 receptors
US6984628B2 (en) * 2003-07-15 2006-01-10 Allergan, Inc. Ophthalmic compositions comprising trefoil factor family peptides
EP1670474A4 (en) * 2003-08-18 2008-08-06 Parion Sciences Inc CYCLIC PYRAZINOYLGUANIDINE AS SODIUM CHANNEL BLOCKER
WO2005107787A1 (en) * 2004-05-06 2005-11-17 Molichem Medicines, Inc. Treatment of membrane-associated diseases and disorders using lantibiotic containing compositions
CA2565545A1 (en) * 2004-05-06 2005-12-08 Molichem Medicines, Inc. Treatment of ocular diseases and disorders using lantibiotic compositions
US7368439B2 (en) * 2005-06-15 2008-05-06 Bar - Ilan University Dinucleoside poly(borano)phosphate derivatives and uses thereof
US7851456B2 (en) * 2005-06-29 2010-12-14 Inspire Pharmaceuticals, Inc. P2Y6 receptor agonists for treating lung diseases
US7998500B2 (en) 2005-08-04 2011-08-16 Vertical Pharmaceuticals, Inc. Nutritional supplement for women
US7901710B2 (en) 2005-08-04 2011-03-08 Vertical Pharmaceuticals, Inc. Nutritional supplement for use under physiologically stressful conditions
US8202546B2 (en) 2005-08-04 2012-06-19 Vertical Pharmaceuticals, Inc. Nutritional supplement for use under physiologically stressful conditions
US8263137B2 (en) 2005-08-04 2012-09-11 Vertical Pharmaceuticals, Inc. Nutritional supplement for women
KR100870104B1 (ko) * 2005-11-28 2008-11-26 주식회사 머젠스 안구건조증 치료 및 예방용 조성물
JP5408882B2 (ja) * 2008-01-23 2014-02-05 ヤマサ醤油株式会社 唾液分泌促進剤
AR086745A1 (es) 2011-06-27 2014-01-22 Parion Sciences Inc 3,5-diamino-6-cloro-n-(n-(4-(4-(2-(hexil(2,3,4,5,6-pentahidroxihexil)amino)etoxi)fenil)butil)carbamimidoil)pirazina-2-carboxamida
HUE032891T2 (hu) 2012-12-17 2017-11-28 Parion Sciences Inc Klórpirazin-karboxamid-származékok nem kielégítõ nyálkahártya-hidratáció által elõsegített megbetegedések kezelésére
RU2671976C2 (ru) 2012-12-17 2018-11-08 Пэрион Сайенсиз, Инк. Соединения 3,5-диамино-6-хлор-n-(n-(4-фенилбутил)карбамимидоил)пиразин-2-карбоксамида
US9102633B2 (en) 2013-12-13 2015-08-11 Parion Sciences, Inc. Arylalkyl- and aryloxyalkyl-substituted epithelial sodium channel blocking compounds
HUE057052T2 (hu) 2016-02-18 2022-04-28 Invirsa Inc 5'-adenozin-difoszfát-ribóz (ADPR) gyógyászati alkalmazása
WO2019191026A2 (en) 2018-03-27 2019-10-03 Invirsa, Inc. Methods for the use of 5'-adenosine diphosphate ribose (adpr)

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4753945A (en) 1986-02-19 1988-06-28 Eye Research Institute Of Retina Foundation Stimulation of tear secretion with phosphodiesterase inhibitors
US4868154A (en) 1986-02-19 1989-09-19 Eye Research Institute Of Retina Foundation Stimulation of tear secretion with melanocyte stimulating hormones
US5635160A (en) * 1995-06-07 1997-06-03 The University Of North Carolina At Chapel Hill Dinucleotides useful for the treatment of cystic fibrosis and for hydrating mucus secretions
US5628984A (en) * 1995-07-31 1997-05-13 University Of North Carolina At Chapel Hill Method of detecting lung disease
US5900407A (en) * 1997-02-06 1999-05-04 Inspire Pharmaceuticals, Inc. Method of treating dry eye disease with uridine triphosphates and related compounds
US5789391A (en) 1996-07-03 1998-08-04 Inspire Pharmaceuticals, Inc. Method of treating sinusitis with uridine triphosphates and related compounds
US6159952A (en) * 1996-11-07 2000-12-12 Inspire Pharmaceuticals, Inc. Method of treating bronchitis with uridine triphosphate and related compounds
EP0981534B1 (en) 1997-02-06 2006-05-03 Inspire Pharmaceuticals, Inc. Dinucleotides and their uses
BR9811612A (pt) * 1997-08-29 2000-08-08 Univ North Carolina Uso de 5' -difosfato de uridina e similares para tratamento de doenças pulmonares
KR20010114214A (ko) 1999-02-26 2001-12-31 인스파이어 파마슈티컬스 인코퍼레이티드 우리딘, 아데닌 및 시티딘 디포스페이트 및 그의 유사체에의한 점막수화 촉진방법

Similar Documents

Publication Publication Date Title
JP4633927B2 (ja) 治療用ジヌクレオチドおよび誘導体
JP4531867B2 (ja) 一定のジヌクレオチドおよび粘膜繊毛クリアランスおよび繊毛運動頻度のモジュレーターとしてのそれらの使用
JP3442773B2 (ja) 抗ウイルス性ヌクレオシドコンビネーション
JP4399478B2 (ja) 1−(2−(ヒドロキシメチル)−1,3−オキサチオラン−5−イル)−5−フルオロシトシンのb型肝炎治療への使用
JP3049258B2 (ja) 新規な抗ウイルス化合物
US6436910B1 (en) Method of promoting mucosal hydration with certain uridine, adenine and cytidine diphosphates and analogs thereof
JP2005015491A5 (cg-RX-API-DMAC7.html)
CA1333361C (en) Antiviral compounds
CZ211496A3 (cs) L-nukleosidy pro léčení hepatitidy viru B a Epstain-Bar viru
WO2000030629A2 (en) Method of promoting cervical and vaginal secretions
JPH09504785A (ja) 抗b型肝炎ウイルス活性を有するヌクレオシド
JP2002505337A5 (cg-RX-API-DMAC7.html)
CN1413113A (zh) 使用嘌呤能受体激动剂治疗胃肠道疾病的方法
JP2005532254A (ja) 炎症性疾患を治療又は予防する方法
Johnson et al. Prostaglandin E2 of the upper aerodigestive tract
WO2025100427A1 (ja) 肺高血圧症の予防および/または治療用医薬
MXPA00011495A (en) Therapeutic dinucleotide and derivatives
MC1766A1 (fr) Procede pour la preparation de 3'-azido-nucleosides et procede pour preparer des formulations pharmaceutiques les contenant
MXPA99007236A (en) Certain dinucleotides and their use as modulators of mucociliary clearance and ciliary beat frequency
NZ217587A (en) 3'-azido nucleosides and derivatives and pharmaceutical composition